These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4062337)

  • 21. Toxic epidermal necrolysis caused by flurazepam?
    Loncar C; Franić T; Bilusić M
    Psychiatr Danub; 2005 Dec; 17(3-4):236-9. PubMed ID: 16392434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
    Yang Y; Xu J; Li F; Zhu X
    Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Toxic epidermal necrolysis. Epidemiologic, clinic and therapeutic aspects at Cotonou University and National Teaching Hospital].
    Aguèmon AR; Houngbé F; Yaméogo TM; Tchaou B; Madougou S; Lokossou T; Hounkpè PC
    Ann Fr Anesth Reanim; 2006 May; 25(5):505-9. PubMed ID: 16545537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efferent methods in the treatment of Lyell's syndrome].
    Novikova RI; Shano VP; Khmel' ON; Abashina TE; Zaĭtsev IuG; Vlodavskiĭ EA
    Sov Med; 1990; (12):108-11. PubMed ID: 2097740
    [No Abstract]   [Full Text] [Related]  

  • 25. Toxic epidermal necrolysis with severe hyperbilirubinemia: complete re-epithelialization after bilirubin reduction therapies.
    Kamada N; Yoneyama K; Togawa Y; Suehiro K; Shinkai H; Yokota M; Matsuda K; Oda S; Hirasawa H; Matsue H
    J Dermatol; 2010 Jun; 37(6):534-6. PubMed ID: 20536667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxic epidermal necrolysis.
    Can Med Assoc J; 1969 Oct; 101(8):126 passim. PubMed ID: 5348481
    [No Abstract]   [Full Text] [Related]  

  • 27. [Toxic epidermal necrolysis induced by NSAID].
    Spornraft-Ragaller P; Ragaller M; Meurer M
    Z Rheumatol; 2003 Oct; 62(5):474-5. PubMed ID: 14579035
    [No Abstract]   [Full Text] [Related]  

  • 28. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxic epidermal necrolysis.
    Edlich RF; Kenney JG; Nichter LS; Silloway KA; Horowitz JH
    Compr Ther; 1986 May; 12(5):43-9. PubMed ID: 3709103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxic epidermal necrolysis induced by sulfonamide eyedrops.
    Fine HF; Kim E; Eichenbaum KD; Antoniades K; Williams CA
    Cornea; 2008 Oct; 27(9):1068-9. PubMed ID: 18812774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose intravenous immunoglobulin in the treatment of toxic epidermal necrolysis: a study of ocular benefits.
    Yip LW; Thong BY; Tan AW; Khin LW; Chng HH; Heng WJ
    Eye (Lond); 2005 Aug; 19(8):846-53. PubMed ID: 15389280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A successful treatment of drug-induced toxic epidermal necrolysis (TEN) by plasma exchange].
    Shimizu T
    Nihon Rinsho; 1992 Jan; 50 Suppl():429-33. PubMed ID: 1578719
    [No Abstract]   [Full Text] [Related]  

  • 34. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine.
    Friedmann PS; Strickland I; Pirmohamed M; Park BK
    Arch Dermatol; 1994 May; 130(5):598-604. PubMed ID: 8179341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe cutaneous adverse reactions to drugs.
    Chia FL; Leong KP
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):304-9. PubMed ID: 17620821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of toxic epidermal necrolysis. Créteil's experience.
    Revuz J; Roujeau JC; Guillaume JC; Penso D; Touraine R
    Arch Dermatol; 1987 Sep; 123(9):1156-8. PubMed ID: 3631999
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug-induced Lyell's syndrome].
    Roujeau JC; Guillaume JC; Flechet ML; Albengres E; Revuz J; Tillement JP; Touraine R
    Therapie; 1984; 39(4):434-7. PubMed ID: 6484887
    [No Abstract]   [Full Text] [Related]  

  • 38. [Toxic epidermal necrolysis and Stevens-Johnson syndrome].
    Roujeau JC
    Rev Prat; 2007 Jun; 57(11):1165-70. PubMed ID: 17691257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma exchange; a promising treatment for toxic epidermal necrolysis with AIDS.
    Nomura T; Abe R; Fujimoto K; Endo T; Shimizu H; Koike T
    AIDS; 2004 Dec; 18(18):2446-8. PubMed ID: 15622328
    [No Abstract]   [Full Text] [Related]  

  • 40. Burn center care for patients with toxic epidermal necrolysis.
    Kelemen JJ; Cioffi WG; McManus WF; Mason AD; Pruitt BA
    J Am Coll Surg; 1995 Mar; 180(3):273-8. PubMed ID: 7874336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.